GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity. [PDF]
Curr Nutr RepSimsek H, Ucar A.
europepmc +1 more source
Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health-Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial. [PDF]
Clin ObesWolsing SK +6 more
europepmc +1 more source
GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists. [PDF]
Diabetes Metab Syndr ObesAbid M, Sheikh KS, Ahmad MS, Jiang H.
europepmc +1 more source
Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. [PDF]
Front ImmunolCiancio G +7 more
europepmc +1 more source
Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial. [PDF]
Diabetes CareBergenstal RM +15 more
europepmc +1 more source
Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and Liraglutide in Adults with Overweight or Obesity without Diabetes: A Comparative Study. [PDF]
Diabetes Metab Syndr ObesCetiner S.
europepmc +1 more source
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. [PDF]
NutrientsBruna-Mejias A +7 more
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]
Gastroenterology ResWeng J +5 more
europepmc +1 more source